Multiple Sclerosis One Year MS-Therapy with Dimethyl Fumarate

被引：0
|
作者：
Wolf, Katrin
机构：
来源：
AKTUELLE NEUROLOGIE | 2015年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [31] Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis
    Yadav, Sudhir Kumar
    Soin, Devika
    Ito, Kouichi
    Dhib-Jalbut, Suhayl
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (04): : 463 - 472
  • [32] Dimethyl fumarate: a novel oral front-line therapy for multiple sclerosis treatment
    van Horssen, Jack
    de Vries, Helga E.
    FUTURE NEUROLOGY, 2013, 8 (03) : 247 - 254
  • [33] Comparison of Natalizumab vs Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience
    Vollmer, Brandi
    Nair, Kavita
    Sillau, Stefan
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    NEUROLOGY, 2017, 88
  • [34] MS-THERAPY AND ITS PATHOGENETIC BASES
    HARRER, G
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1985, 135 (1-2) : 42 - 45
  • [35] Comparison of natalizumab vs fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: two year experience
    Vollmer, B. L.
    Nair, K. V.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 856 - 857
  • [36] Study update for MS-therapy with Natalizumab
    Wolf, Katrin
    AKTUELLE NEUROLOGIE, 2008, 35 (10) : 544 - 544
  • [37] Reword-ms: real world study to assess the response to dimethyl fumarate in patients with multiple sclerosis
    Creta, M. F.
    Tramacere, I.
    Roldan, E. Tomas
    Confalonieri, P.
    Clerici, V. Torri
    Antozzi, C.
    Mantegazza, R.
    Tozzo, A.
    Brambilla, L.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 189 - 190
  • [38] CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
    Ann-Kathrin Kogel
    Ralf Gold
    Ruth Schneider
    Journal of Neurology, 2021, 268 : 4374 - 4375
  • [39] Safety and efficacy of dimethyl fumarate in multiple sclerosis - an observational study
    Miclea, A.
    Hoepner, R.
    Leussink, V. I.
    Hartung, H. -P.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 597 - 598
  • [40] Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
    Vollmer, Brandi L.
    Nair, Kavita V.
    Sillau, Stefan
    Corboy, John R.
    Vollmer, Timothy
    Alvarez, Enrique
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02): : 252 - 262
12345